Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 5

Current concepts in the management of hepatopulmonary syndrome

Authors Vincent Ho

Published 10 October 2008 Volume 2008:4(5) Pages 1035—1041

DOI https://doi.org/10.2147/VHRM.S3608

Review by Single-blind

Peer reviewer comments 4

Vincent Ho

School of Medicine, James Cook University, Cairns, Queensland, Australia

Abstract: The hepatopulmonary syndrome is characterized as the triad of liver disease, pulmonary gas exchange abnormalities leading to arterial deoxygenation and evidence of intrapulmonary vascular dilatations. This review summarizes the pathological mechanisms leading to pulmonary vascular changes in hepatopulmonary syndrome. The role of the three currently used diagnostic imaging modalities of contrast-enhanced echocardiography, perfusion lung scanning and pulmonary arteriography that identify the presence of intrapulmonary vascular abnormalities are reviewed. Liver transplantation is considered to be the definitive treatment of hepatopulmonary syndrome with often successful reversal of hypoxaemia, however other treatments have been trialed. This review further appraises the evidence for the use of pharmacological agents and the role of radiological interventions in hepatopulmonary syndrome.

Keywords: hepatopulmonary syndrome, liver cirrhosis, lung diseases

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Clinical experiences in fungal keratitis caused by Acremonium

Kim SJ, Cho YW, Seo SW, Kim SJ, Yoo JM

Clinical Ophthalmology 2014, 8:283-287

Published Date: 23 January 2014

Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia

Catalin Mindrescu, Rakesh P Gupta, Eileen V Hermance, Mary C DeVoe, Vikas R Soma, et al

Vascular Health and Risk Management 2008, 4:1439-1447

Published Date: 5 December 2008

Corrigendum

Dove Medical Press Editorial

Vascular Health and Risk Management 2008, 4:1481-1481

Published Date: 5 December 2008

Compliance of the aorta in two diseases affecting vascular elasticity, familial hypercholesterolemia and diabetes: a MRI study

Sami Soljanlahti, Taina Autti, Laura Hyttinen, Alpo F Vuorio, Pekka Keto, Kirsi Lauerma

Vascular Health and Risk Management 2008, 4:1103-1109

Published Date: 10 October 2008

Editorial: Clinical Ophthalmology and PubMed   ||Free paper||

Scott G Fraser

Clinical Ophthalmology 2008, 2:0-0

Published Date: 12 September 2008

The interleukin-6 –174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study

Mark PS Sie, Francesco US Mattace-Raso, André G Uitterlinden, Pascal P Arp, Albert Hofman, et al

Vascular Health and Risk Management 2008, 4:863-869

Published Date: 8 August 2008

Comparative evaluation of 64-slice CT angiography and digital subtraction angiography in assessing the cervicocranial vasculature

Randolf Klingebiel, Max Kentenich, Hans-Christian Bauknecht, Florian Masuhr, Eberhard Siebert, et al

Vascular Health and Risk Management 2008, 4:901-907

Published Date: 8 August 2008

Cardiovascular co-morbidity in rheumatic diseases

Carl Turesson, Lennart TH Jacobsson, Eric L Matteson

Vascular Health and Risk Management 2008, 4:605-614

Published Date: 6 June 2008

Venlafaxine in the treatment of panic disorder

Martin A Katzman, Leslie Jacobs

Neuropsychiatric Disease and Treatment 2007, 3:59-67

Published Date: 15 March 2007